Integrative Onkologie – Komplementärmedizinische Therapieansätze in der gynäkologischen Onkologie – Nutzen und Grenzen

Nach Angaben der Deutschen Krebshilfe interessieren sich in Deutschland 70% der Krebspatienten im Verlauf ihrer Krankheitsgeschichte für komplementärmedizinische Behandlungsmöglichkeiten. Leider sprechen die wenigsten Patienten mit ihrem Onkologen darüber, was bei unsachgemäßer Anwendung zu unerfreulichen Neben- und Wechselwirkungen führen kann [1] . Die integrative Onkologie steht für eine evidenzbasierte begleitende komplementärmedizinische Behandlung in enger Absprache mit den (Gynäko-) Onkologen. Ziel sind die Linderung von Nebenwirkungen der onkologischen Therapie, die Verbesserung der Lebensqualität und die Förderung eines gesundheitsorientierten Lebensstils.

• Literatur

• 1 Anderson MR, Sweet E, Lowe KA et al. Dangerous combinations: ingestible CAM – supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med 2013; 19: 714-720
• 2 Dobos G, Klose P, Voiss P et al. Hot Topic: Mammakarzinom & gynäkologische Tumore –supportive Therapiemöglichkeiten aus der Integrativen Onkologie. GynOnko Update 2014; med publico Wiesbaden
• 3 Nelson G, Altman AD, Nick A et al. Guidelines for pre- and intra-operative care in gynecology / oncology surgery: enhanced recovery after surgery (ERAS ®) society recommendations – part I. Gynecol Oncol 2016; 140: 313-322
• 4 Nelson G, Altman AD, Nick A et al. Guidelines for pre- and intra-operative care in gynecology / oncology surgery: enhanced recovery after surgery (ERAS ®) society recommendations- part II. Gynecol Oncol 2016; 140: 323-332
• 5 Wilms H, Mittal A, Haydock MD et al. A systematic review of goal directed fluid therapy: rating of evidence for goals and monitoring methods. J Crit Care 2014; 29: 204-209
• 6 Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer 2009; 17: 333-337
• 7 Sook-Hyun L, Jong-Yeop K, Sujung Y et al. Meta-analysis of massage therapy on cancer pain. Integr Cancer Ther 2015; 14: 297-304
• 8 Gross AH, Cromwell J, Fonteyn M et al. Hopelessness and complementary therapy use in patients with ovarian cancer. Cancer Nurs 2013; 36: 256-264
• 9 Ertas IE, Gungorduk K, Ozdemir A et al. Influence of gum chewing on postoperative bowel activity after complete staging surgery for gynecological malignancies: a randomized controlled trial. Gynecol Oncol 2013; 131: 118-122
• 10 Unger C et al. Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer. Arneim Forsch 2001; 51: 332-338
• 11 Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Annals Oncol 2014; 25: 1919-1929
• 12 Romoli M, Allais G, Airola G et al. Ear acupuncture and fMRI: a pilot study for assessing the specificity of auricular points. Neurol Sci 2014; 35 Suppl 1: 189-193
• 13 Frangos E, Ellrich J, Komisaruk BR. Non-invasive access to the vagus nerve. Central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain Stimul 2015; 8: 624-636
• 14 Hwang E, Shin S. The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. J Altern Complement Med 2015; 21: 1-8
• 15 Simões-Wüst AP, Al Hassani T, Müller-Hübenthal B et al. Sleep quality improves during treatment with bryophyllum pinnatum: an observational study on cancer patients. Integr Cancer Ther 2015; 1-8
• 16 Broadbent E, Kahokehr A, Booth RJ et al. A brief relaxation intervention reduces stress and improves surgical wound healing response: A randomised trial. Brain Behav Immun 2012; 26: 212-217
• 17 Dobos G, Overhamm T, Büssing A et al. Integrating mindfulness in supportive cancer care: a cohort study on a mindfulness-based day care clinic for cancer survivors. Support Care Cancer 2015; 23: 2945-2955
• 18 Lutgendorf SK, Sood AK, Anderson B et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 2005; 23: 7105-7113
• 19 Nagaraja AS, Armaiz-Pena GN, Lutgendorf SK et al. Why stress is bad for cancer patients. J Clin Invest 2013; 123: 558-560
• 20 Lutgendorf SK, De Geest K, Bender D et al. Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 2012; 30: 2885-2890
• 21 Satin JR, Linden W, Phillips MJ et al. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115: 5349-5361
• 22 Thaker PH, Han LY, Kamat AA et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12: 939-944
• 23 Chida Y, Hamer M, Wardle J et al. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat Clin Pract Oncol 2008; 5: 466-475
• 24 Deng G, Frenkel M, Cohen L et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 2009; 7: 85-120